News and Media

MMS ANNOUNCES ONE MILLION DOLLAR AWARD FOR PHARMACEUTICAL COMPANIES DEVELOPING A VACCINE FOR COVID-19

MMS ANNOUNCES ONE MILLION DOLLAR AWARD FOR PHARMACEUTICAL COMPANIES DEVELOPING A VACCINE FOR COVID-19

Canton, Mich. (March 20, 2020) — MMS Holdings announced today that it is offering a USD1M award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered in the form of data and related services to qualified pharmaceutical and clinical research companies supporting the commercial development of a vaccine for approval in the United States and/or other global health authorities.

MMS HOLDINGS TO DEBUT DATACISE INTEGRATED SAFETY EXPLORER TO DETECT SAFETY SIGNALS USING REAL-WORLD EVIDENCE DURING PHUSE/FDA DATA SCIENCE INNOVATION CHALLENGE

MMS HOLDINGS TO DEBUT DATACISE INTEGRATED SAFETY EXPLORER TO DETECT SAFETY SIGNALS USING REAL-WORLD EVIDENCE DURING PHUSE/FDA DATA SCIENCE INNOVATION CHALLENGE

CANTON, Mich. (March 4, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that the Datacise Integrated Safety Explorer will make its debut at the 2020 PHUSE U.S. Connect conference in Orlando, Florida as part of the PHUSE/FDA Data Science Innovation Challenge, where, according to PHUSE, the “greatest minds in the data sciences arena come together and collaborate.”

MMS HOLDINGS EXECUTIVE MICHELLE GAYARI JOINS ADVISORY BOARD OF INTERNATIONAL NONPROFIT THAT PROVIDES EDUCATIONAL PROGRAMS TO CHILDREN IN HOSPITALS

MMS HOLDINGS EXECUTIVE MICHELLE GAYARI JOINS ADVISORY BOARD OF INTERNATIONAL NONPROFIT THAT PROVIDES EDUCATIONAL PROGRAMS TO CHILDREN IN HOSPITALS

CANTON, Mich. (October 23, 2019) – MMS Holdings – an award-winning, data-focused CRO – announced today that its Executive Director of Global Operations Michelle Gayari has joined the advisory board for the international 501(c)(3) charity Together Educating All Children in Hospitals (TEACH). As its sole board member in the state of Michigan, Gayari will provide leadership, guidance, and fundraising support to help in bringing exciting, hands-on educational programs to children in hospitals.

MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers

MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers

CANTON, Mich. (June 27, 2019) – MMS announced today the launch of Automatiqc™ (pronounced: automatic). Automatiqc is a new cloud-based application that automatically performs quality control (QC) and style checks for medical writing, pharmacovigilance, clinical trial transparency, and other types of documents in the pharmaceutical, biotechnology, and medical device industries.

Media Contact

Don McLean, MBA
Sr. Manager, Global Marketing & Communications
6880 Commerce Blvd.
Canton, MI 48187 USA
734. 245.0165
media@mmsholdings.com

 

6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

Email Us

LinkedIn

 

Facebook

Learn more about working with MMS

4 + 2 =

© MMS Holdings Inc. All rights reserved. Privacy Policy